Neurocognitive Outcome and Compensating Possibilities in Children and Adolescents Treated for Acute Lymphoblastic Leukemia With Chemotherapy Only

被引:13
|
作者
Lofstad, Grete Elisabeth [1 ]
Reinfjell, Trude [1 ,2 ]
Weider, Siri [1 ]
Diseth, Trond H. [3 ,4 ]
Hestad, Knut [1 ,5 ,6 ]
机构
[1] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway
[2] St Olavs Univ Hosp, Dept Child & Adolescent Psychiat, Trondheim, Norway
[3] Oslo Univ Hosp, Div Paediat & Adolescent Med, Dept Child & Adolescent Mental Hlth Hosp, Oslo, Norway
[4] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
[5] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway
[6] Inland Norway Univ Appl Sci, Dept Hlth & Nursing Sci, Elverum, Norway
来源
FRONTIERS IN PSYCHOLOGY | 2019年 / 10卷
关键词
acute lymphoblastic leukemia; survivors; neurocognitive; long-term sequelae; compensating possibilities; SURVIVORS; IMPAIRMENT; METAANALYSIS; SEQUELAE;
D O I
10.3389/fpsyg.2019.01027
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Aim: To examine the neurocognitive outcomes in children and adolescents with acute lymphoblastic leukemia (ALL) in remission who were treated with systemic chemotherapy only (CTO). Methods: Neurocognitive performances in 36 children and adolescents, aged 8.4-15.3 years, in long-term remission from ALL 4.3-12.4 years post diagnosis, without relapse, and with no pre-diagnosis history of neurodevelopmental disorder were compared with 36 healthy controls matched for gender, age, and parents' socio-economic status. The former patients and the healthy controls completed an extensive battery of standardized neuropsychological tests. Results: Survivors who were treated by CTO obtained significantly lower scores than did healthy controls on the domains of Copy and drawing (p = 0.001; Cohen's d 0.85; after controlling for Type 1 errors q = 0.006), Arithmetic (p = 0.001; Cohen's d 0.80; after controlling for Type 1 errors, q = 0.006), and Tactile sensory functions (p = 0.008; Cohen's d 0.65; after controlling for Type 1 errors, q = 0.03). Fifty percent of the ALL group were more than 1 SD below the control groups mean on Copy and drawing. There was an interaction between age and group (ALL vs. Control, p = 0.042) on Copy and drawing, indicating that the youngest ALL patients exhibited the worst performance. The oldest ALL patients performed equal to or better than the controls. A tendency in the same direction was seen for Arithmetic and Tactile sensory functions. The ALL survivors exhibited a steeper rising learning slope on repeated tests, with lower scores on a tactile problem-solving task, tactile sensory tests, verbal memory, and visual attention, but they performed as well as the controls when stimuli were repeated. Conclusion: The results indicate that neurocognitive long-term sequelae in ALL survivors are limited to specific domains - particularly complex drawing, arithmetic, and tactile processing, and novelty processing. Cognitive deficits are shown among the youngest ALL patients. Intervention programs and school programs should account for difficulties with processing new information and taking advantage of repetitions as a strength, which may prevent survivors from falling behind their peers.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: A systematic review
    Hearps, Simone
    Seal, Marc
    Anderson, Vicki
    McCarthy, Maria
    Connellan, Madeleine
    Downie, Peter
    De Luca, Cinzia
    PEDIATRIC BLOOD & CANCER, 2017, 64 (02) : 225 - 233
  • [22] Pneumococcal vaccination during chemotherapy in children treated for acute lymphoblastic leukemia
    Dorval, Sarah
    Gantt, Soren
    Leclerc, Jean-Marie
    Laverdiere, Caroline
    Ovetchkine, Philippe
    Tapiero, Bruce
    PEDIATRIC BLOOD & CANCER, 2021, 68 (06)
  • [23] Possibilities of chemotherapy of acute lymphoblastic leukemia in adults.
    Moiseev, SI
    Abdulkadyrov, KM
    Martynkevich, IS
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2001, 46 (02): : 9 - 14
  • [24] OUTCOME OF CHILDREN TREATED FOR RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA IN CENTRAL AMERICA
    Marjerrison, Stacey
    Antillion, Federico
    Fu, Ligia
    Vasquez, Roberto
    Sung, Lillian
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1005 - 1005
  • [25] Outcome of children treated for relapsed acute lymphoblastic leukemia in Central America
    Marjerrison, Stacey
    Antillon, Federico
    Fu, Ligia
    Martinez, Roxana
    Vasquez, Roberto
    Bonilla, Miguel
    Howard, Scott C.
    Sung, Lillian
    CANCER, 2013, 119 (06) : 1277 - 1283
  • [26] Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only
    Mennes, M
    Stiers, P
    Vandenbussche, E
    Vercruysse, G
    Uyttebroeck, A
    De Meyer, G
    Van Gool, SW
    PEDIATRIC BLOOD & CANCER, 2005, 44 (05) : 479 - 486
  • [27] Motor function in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy-only
    Goebel, A. -M.
    Koustenis, E.
    Rueckriegel, S.
    Pfuhlmann, L.
    Brandsma, R.
    Sival, D.
    Skarabis, H.
    Schuelke, M.
    Driever, P. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 199 - 199
  • [28] Motor function in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy-only
    Goebel, Anna-Maria
    Koustenis, Elisabeth
    Rueckriegel, Stefan M.
    Pfuhlmann, Laura
    Brandsma, Rick
    Sival, Deborah
    Skarabis, Horst
    Schuelke, Markus
    Driever, Pablo Hernaiz
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2019, 23 (02) : 304 - 316
  • [29] Treatment outcome of adolescents with acute lymphoblastic leukemia
    G. İrken
    H. Ören
    H. Gülen
    M. Duman
    C. Uçar
    B. Atabay
    Ş. Yılmaz
    K. Uysal
    N. Çevik
    Annals of Hematology, 2002, 81 : 641 - 645
  • [30] Treatment outcome of adolescents with acute lymphoblastic leukemia
    Irken, G
    Ören, H
    Gülen, H
    Duman, M
    Uçar, C
    Atabay, B
    Yilmaz, S
    Uysal, K
    Çevik, N
    ANNALS OF HEMATOLOGY, 2002, 81 (11) : 641 - 645